Taking the evidence derived from the patients with gall bladder cancer into account, we speculate that immunonutrition may be associated with a more favorable outcome compared to standard nutrition owing to its impact on CD4+/CD8+ ratio. The gene discussed is CD4; the disease is gallbladder cancer.